title: Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
abstract: Infections with herpes simplex virus (HSV) types 1 and 2 and herpes zoster are common and a substantial public health issue. Famciclovir is an effective treatment for herpes simplex and herpes zoster. We review studies evaluating the efficacy of single-day doses of famciclovir for the treatment of recurrent herpes labialis (cold sores) and genital herpes. Famciclovir has received single-day dosing indications for both of these entities. The studies leading to these new indications are reviewed.
authors.affiliation: Department of Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, New York, NY 10025, USA.
authors.forename: Manju
authors.initials: M
authors.lastname: Chacko
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Weinberg
mesh_terms: D015075:2-Aminopurine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D000077595:Famciclovir; D006558:Herpes Genitalis / Q000188:drug therapy*; D006560:Herpes Labialis / Q000188:drug therapy*; D006801:Humans; D012008:Recurrence
chemical_list: D000998:Antiviral Agents; D015075:2-Aminopurine; D000077595:Famciclovir